CHRS — Coherus Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Coherus Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	541	417	192	118	126
Net Total Accounts Receivable
Net Total Receivables	157	123	110	261	122
Total Inventory
Prepaid Expenses
Total Current Assets	767	602	381	476	342
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	20.1	16	14.4	11	7.36
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	842	679	481	630	449
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	146	165	139	332	283
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	561	582	618	823	581
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	281	97.7	-137	-193	-132
Total Liabilities & Shareholders' Equity	842	679	481	630	449
Total Common Shares Outstanding